Direct stimulation of bone resorption by thyroid hormones.

Although hypercalcemia, osteoporosis, and increased bone turnover are associated with thyrotoxicosis, no direct effects of thyroid hormones on bone metabolism have been reported previously in organ culture. We have now demonstrated that prolonged treatment with thyroxine (T4) or triiodothyronine (T3) can directly increase bone resorption in cultured fetal rat long bones as measured by the release of previously incorporated 45Ca. T4 and T3 at 1 muM to 10 nM increased 45Ca release by 10-60% of total bone 45Ca during 5 days of culture. The medium contained 4 mg/ml of bovine serum albumin to which 90% of T4 and T3 were bound, so that free concentrations were less than 0.1 muM. The response to T4 and T3 was inhibited by cortisol (1 muM) and calcitonin (100 mU/ml). Indomethacin did not inhibit T4 response suggesting that T4 stimulation of bone resorption was not mediated by increased prostaglandin synthesis by the cultured bone. Matrix resorption was demonstrated by a decrease in extracted dry weight and hydroxyproline concentration of treated bones and by histologic examination which also showed increased osteoclast activity. The effects of thyroid hormones were not only slower than those of other potent stimulators of osteoclastic bone resorption (parathyroid hormone, vitamin D metabolites, osteoclast activating factor, and prostaglandins), but the maximum response was not as great. We conclude that T4 and T3 can directly stimulate bone resorption in vitro at concentrations approaching those which occur in thyrotoxicosis. This effect may explain the disturbances of calcium metabolism seen in hyperthyroidism.

[1]  Follis Rh Skeletal changes associated with hyperthyroidism. , 1953 .

[2]  R. Marcus Cyclic nucleotide phosphodiesterase from bone: characterization of the enzyme and studies of inhibition by thyroid hormones. , 1975, Endocrinology.

[3]  E. Canalis,et al.  Hormonal control of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin. , 1976, Endocrinology.

[4]  L. Raisz BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. , 1965, The Journal of clinical investigation.

[5]  D. Klein,et al.  Prostaglandins: stimulation of bone resorption in tissue culture. , 1970, Endocrinology.

[6]  L. Raisz,et al.  Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. , 1969, Endocrinology.

[7]  G. Mundy,et al.  Bone-resorbing activity in supernatants from lymphoid cell lines. , 1974, The New England journal of medicine.

[8]  S. Krane,et al.  The effect of thyroid disease on calcium metabolism in man. , 1956, The Journal of clinical investigation.

[9]  G. Aurbach,et al.  The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro. , 1970, The Journal of biological chemistry.

[10]  F. Singer,et al.  Treatment of thyrotoxic hypercalcemia with propranolol. , 1976, New England Journal of Medicine.

[11]  S. Genuth,et al.  Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism. , 1975, Metabolism: clinical and experimental.

[12]  B. Karlberg,et al.  Cyclic adenosine 3',5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism. , 1974, The Journal of clinical endocrinology and metabolism.

[13]  M. Herrmann‐Erlee,et al.  The effects of dibutyryl cyclic AMP, aminophylline and propranolol on PTE-induced bone resorption in vitro. , 1974, Endocrinology.

[14]  D. Klein,et al.  Role of adenosine-3',5'-monophosphate in the hormonal regulation of bone resorption: studies with cultured fetal bone. , 1971, Endocrinology.

[15]  R. Harden,et al.  SOME EFFECTS OF PARATHYROID HORMONE IN THYROTOXICOSIS. , 1964, The Journal of clinical endocrinology and metabolism.

[16]  Lawrence G. Raisz,et al.  Complement-Dependent Stimulation of Prostaglandin Synthesis and Bone Resorption , 1974, Science.

[17]  G. Mundy,et al.  Effect of osteoclast activating factor from human leukocytes on bone metabolism. , 1975, The Journal of clinical investigation.

[18]  R. Volpe,et al.  Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF). , 1973, The Journal of clinical endocrinology and metabolism.

[19]  R. H. Follis Skeletal changes associated with hyperthyroidism. , 1953, Bulletin of the Johns Hopkins Hospital.

[20]  S. Reichlin,et al.  Measurement of plasma and tissue triiodothyronine concentration in the rat by radioimmunoassay. , 1975, Endocrinology.

[21]  S. Mergenhagen,et al.  Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood Leukocytes , 1972, Science.

[22]  P. T. Cheng,et al.  An improved method for the determination of hydroxyproline in rat skin. , 1969, The Journal of investigative dermatology.

[23]  P. Gaillard Observations on the effect of thyroid and parathyroid secretions on explanted mouse radius rudiments. , 1963, Developmental biology.

[24]  P. Kelly,et al.  EFFECTS OF HYPERTHYROIDISM ON BONE AND MINERAL METABOLISM IN MAN , 1967 .

[25]  J. Biggers,et al.  Growth of embryonic avian and mammalian tibiae on a relatively simple chemically defined medium. , 1961, Experimental cell research.

[26]  R. Askenasi,et al.  Urinary excretion of hydroxylysyl glycosides and thyroid function. , 1975, The Journal of clinical endocrinology and metabolism.

[27]  S. Fraser,et al.  Hyperthyroidism and calcium metabolism. , 1973, Clinics in endocrinology and metabolism.